ProPhase Labs, Inc.
PRPH
$0.3288
-$0.0063-1.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.59M | 5.85M | 6.77M | 1.11M | 6.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.59M | 5.85M | 6.77M | 1.11M | 6.32M |
| Cost of Revenue | 4.26M | 5.41M | 6.92M | 5.22M | 7.95M |
| Gross Profit | 1.33M | 436.00K | -150.00K | -4.12M | -1.63M |
| SG&A Expenses | 32.37M | 34.68M | 37.89M | 28.84M | 29.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.92M | 40.51M | 45.40M | 34.86M | 38.62M |
| Operating Income | -31.33M | -34.66M | -38.63M | -33.76M | -32.30M |
| Income Before Tax | -34.86M | -38.92M | -42.33M | -36.20M | -33.89M |
| Income Tax Expenses | 12.83M | 9.76M | 7.20M | -10.28M | -9.41M |
| Earnings from Continuing Operations | -47.69 | -48.68 | -49.53 | -25.92 | -24.48 |
| Earnings from Discontinued Operations | 6.24M | 5.55M | -3.84M | -1.43M | -1.43M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.45M | -43.13M | -53.36M | -27.76M | -26.31M |
| EBIT | -31.33M | -34.66M | -38.63M | -33.76M | -32.30M |
| EBITDA | -25.45M | -28.60M | -32.44M | -26.61M | -25.74M |
| EPS Basic | -1.93 | -2.15 | -2.61 | -1.52 | -1.47 |
| Normalized Basic EPS | -0.86 | -1.08 | -1.28 | -1.24 | -1.19 |
| EPS Diluted | -1.94 | -2.15 | -2.61 | -1.52 | -1.47 |
| Normalized Diluted EPS | -0.86 | -1.08 | -1.28 | -1.24 | -1.19 |
| Average Basic Shares Outstanding | 116.32M | 93.66M | 76.48M | 73.22M | 71.32M |
| Average Diluted Shares Outstanding | 116.32M | 93.66M | 76.48M | 73.22M | 71.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |